Cargando…
Myxoedema Coma Masquerading as Acute Stroke
This report describes the management of a patient with myxoedema coma masquerading as an acute stroke (with or without ‘cold sepsis’). Myxoedema coma is an endocrine emergency occurring when physiological adaptations to untreated hypothyroidism are overwhelmed by an acute precipitant. Even promptly...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350959/ https://www.ncbi.nlm.nih.gov/pubmed/32665924 http://dx.doi.org/10.12890/2020_001563 |
_version_ | 1783557369689538560 |
---|---|
author | Butter, Christopher Rashid, Nazia Banatwalla, Rumaisa FitzGerald, Thomas |
author_facet | Butter, Christopher Rashid, Nazia Banatwalla, Rumaisa FitzGerald, Thomas |
author_sort | Butter, Christopher |
collection | PubMed |
description | This report describes the management of a patient with myxoedema coma masquerading as an acute stroke (with or without ‘cold sepsis’). Myxoedema coma is an endocrine emergency occurring when physiological adaptations to untreated hypothyroidism are overwhelmed by an acute precipitant. Even promptly treated, it has an associated mortality of up to 50%. LEARNING POINTS: Early recognition of myxoedema coma is essential, however the chance of misdiagnosis remains high. Key management consists of rapid thyroid hormone replacement (intravenous T4 at 300–500 μg over 24 hours, followed by 50–100 μg daily), supportive measures and the concomitant management of triggers such as infection. |
format | Online Article Text |
id | pubmed-7350959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-73509592020-07-13 Myxoedema Coma Masquerading as Acute Stroke Butter, Christopher Rashid, Nazia Banatwalla, Rumaisa FitzGerald, Thomas Eur J Case Rep Intern Med Articles This report describes the management of a patient with myxoedema coma masquerading as an acute stroke (with or without ‘cold sepsis’). Myxoedema coma is an endocrine emergency occurring when physiological adaptations to untreated hypothyroidism are overwhelmed by an acute precipitant. Even promptly treated, it has an associated mortality of up to 50%. LEARNING POINTS: Early recognition of myxoedema coma is essential, however the chance of misdiagnosis remains high. Key management consists of rapid thyroid hormone replacement (intravenous T4 at 300–500 μg over 24 hours, followed by 50–100 μg daily), supportive measures and the concomitant management of triggers such as infection. SMC Media Srl 2020-04-22 /pmc/articles/PMC7350959/ /pubmed/32665924 http://dx.doi.org/10.12890/2020_001563 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Articles Butter, Christopher Rashid, Nazia Banatwalla, Rumaisa FitzGerald, Thomas Myxoedema Coma Masquerading as Acute Stroke |
title | Myxoedema Coma Masquerading as Acute Stroke |
title_full | Myxoedema Coma Masquerading as Acute Stroke |
title_fullStr | Myxoedema Coma Masquerading as Acute Stroke |
title_full_unstemmed | Myxoedema Coma Masquerading as Acute Stroke |
title_short | Myxoedema Coma Masquerading as Acute Stroke |
title_sort | myxoedema coma masquerading as acute stroke |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350959/ https://www.ncbi.nlm.nih.gov/pubmed/32665924 http://dx.doi.org/10.12890/2020_001563 |
work_keys_str_mv | AT butterchristopher myxoedemacomamasqueradingasacutestroke AT rashidnazia myxoedemacomamasqueradingasacutestroke AT banatwallarumaisa myxoedemacomamasqueradingasacutestroke AT fitzgeraldthomas myxoedemacomamasqueradingasacutestroke |